Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon: a single-center retrospective cohort study
BACKGROUND: The no-reflow phenomenon is associated with a considerable reduction in myocardial salvage in patients with ST elevation myocardial infarction (STEMI) treated by primary percutaneous intervention (PCI). There has been no head-to-head comparison of intra-coronary epinephrine to adenosine...
Saved in:
| Main Authors: | Ahmed Darwish, Abdel-Fattah Frere, Magdy Abdelsamie, Waleed El Awady, Mohammad Gouda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
King Faisal Specialist Hospital and Research Centre
2022-03-01
|
| Series: | Annals of Saudi Medicine |
| Online Access: | http://www.annsaudimed.net/doi/10.5144/0256-4947.2022.75 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intracoronary epinephrine and verapamil in the refractory no-reflow phenomenon in patients with acute myocardial infarction
by: S. V. Dil, et al.
Published: (2022-01-01) -
NO-REFLOW PHENOMENON IN THE PRACTICE OF AN ENDOVASCULAR SURGEON
by: A. M. Gerasimov, et al.
Published: (2016-06-01) -
Index of Microcirculatory Resistance Measured during Intracoronary Adenosine-Induced Hyperemia
by: Irene Santos-Pardo, et al.
Published: (2020-01-01) -
No-reflow phenomenon and reperfusion injury. Mechanisms and treatment
by: M. Yu. Gilyarov, et al.
Published: (2022-03-01) -
Effectiveness of Glucocorticoids in the No-Reflow Phenomenon in STEMI Patients
by: Maksim Y. Sokolov, et al.
Published: (2025-03-01)